课题基金 / 基金详情

Development of new bioactive composite materials for bone regeneration

Development of new bioactive composite materials for bone regeneration
用于骨再生的新型生物活性复合材料的开发
批准号:
BB/F018312/1
负责人:
金额:
$10.26万
依托单位:
依托单位国家:
英国
项目类别:
Training Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
该项目旨在开发新的肌肉骨骼替代材料,以满足关键的临床需求。照顾婴儿潮一代的经济和社会负担,因为他们进入了骨科干预和骨质疏松症的高峰年龄范围,可以通过新的生物材料治疗来解决。开发的材料也将使生物陶瓷治疗公司在市场上比同类材料具有竞争优势。正如Stevens博士最近在《科学》杂志(Stevens and George, Science 2005)上所强调的那样,由纳米纤维构成的三维基质可以使细胞在具有与其天然细胞外基质相似规模特征的环境中生长。纳米纤维结构似乎更有可能提供线索,刺激细胞表达合适的表型,将自己组织成生理上相关的组织样结构。传统的大孔聚合物或陶瓷支架缺乏这些地形线索。这种模仿自然基质的“仿生”结构的概念——生物材料和组织工程界的一个关键研究目标——只能通过涉及生物和物理科学的跨学科研究来实现。该项目涉及制造一种基于聚γ -谷氨酸(PgGA)的电纺纳米纤维支架。与用于纳米纤维的其他材料相比,PgGA具有许多优点;高强度,酶降解性和非免疫原性。在结构上,它的β薄片结构类似于其他高强度的天然纤维,如丝素或丝绸,但它的生产成本只是后者的一小部分。细菌产生的PgGA可以产生几乎100%结晶的高强度纤维。史蒂文斯博士实验室中定制的静电纺丝设备可以与这种聚合物一起生产高强度的纳米纤维基质。然后,这种基质可以与生物陶瓷治疗公司内部开发的生物活性陶瓷相结合,生成用于生物活性组织工程支架的纳米纤维增强复合材料。我们将研究初代成骨细胞(HOBs)和SaOs-2矿化成骨细胞系与支架的相互作用。最初的细胞分析将检查对材料的反应,并将重点放在材料支持细胞分化的能力上。纤维/生物活性玻璃复合材料为研究纳米纤维和表面化学对细胞活性的影响提供了许多独特的机会。利用静电纺丝系统,可以制造化学成分相似但厚度不同的纤维,以控制纳米级的形貌。此外,通过聚合物主链的功能化来控制聚合物化学将控制蛋白质对材料的吸附。细胞与材料在体外的相互作用将通过播种细胞、测量代谢活性、酶碱性磷酸酶活性和骨钙素等标志物的产生来评估。最终矿化将通过四环素染色标记细胞沉积的钙离子来测量。通过骨钙素,骨碱性磷酸酶和胶原蛋白的实时RT-PCR分析来测量细胞通过分化途径的进展。工作计划:静电纺丝PgGA: IC(0-6月)静电纺丝纤维的表征:IC(3-12月)生物陶瓷BCT的制造和表征(12-18月)纤维的功能化:IC(18-21月)纤维/生物陶瓷复合材料的工程BCT + IC(22-28月)纤维和复合材料的体外细胞生物相容性测定:IC(29-36月)纤维材料的扩大和无菌生产:BCT + IC(37-42月)合作安排:帝国理工学院的博士将由Molly Stevens博士与BioCeramic Therapeutics Ltd合作
英文摘要
Development of New Bioactive Composite Materials for Bone Regeneration This project aims to develop new musculoskeletal replacement materials to meet critical clinical needs. The economic and social burden of caring for the baby boomer generation as it enters the peak age range for orthopaedic interventions and osteoporosis can be addressed with new biomaterials based treatments. The materials developed will also allow BioCeramic Therapeutics to develop a competitive advantage over similar materials in the marketplace. As highlighted by Dr Stevens recently in Science (Stevens and George, Science 2005), a three dimensional matrix constructed of nanofibres allows cells to grow in an environment with features on a similar scale to their natural extracellular matrices. Nanofibrous structures appear more likely to present cues which stimulate cells to express a suitable phenotype to organise themselves into physiologically relevant tissue-like structures. Conventional macroporous polymer or ceramic scaffolds lack these topographical cues. This concept of 'biomimetic' structures which mimic natural matrices - a key research goal of the biomaterials and tissue engineering community- can only be achieved through interdisciplinary research involving input from biological and physical sciences. The project involves the fabrication of an electrospun nanofibrous scaffold based on poly-gamma-glutamic acid (PgGA). PgGA has a number of advantages over other materials used for nanofibres; high strength, enzymatic degradability and is non-immunogenic. Structurally, its beta sheet structure is similar to other high strength natural fibres such as fibroin or silk, but it can be produced at a fraction of the cost. Bacterially produced PgGA can generate an almost 100% crystalline high strength fibre. The custom-designed electrospinning apparatus in Dr Stevens' laboratory can be used with this polymer to produce a high strength nanofibrous matrix. This matrix can then be combined with bioactive ceramics developed in-house at BioCeramic Therapeutics to generate nanofibre reinforced composite materials for bioactive tissue engineering scaffolds. We will examine the interaction of primary osteoblasts (HOBs) and a SaOs-2 mineralizing osteoblast cell line, with the scaffolds. Initial cell assays will examine responses to the materials, and will concentrate on the capacity of the materials to support cell differentiation. The fibre/bioactive glass composites offer a number of unique opportunities to examine both the influence of nanoscale fibres and surface chemistry on cell activity. Using the electrospinning system, fibres of similar chemistry but varying thicknesses can be fabricated, to control nanoscale topography. Additionally, control of polymer chemistry through functionalisation of the polymer backbone will control protein adsorption to the material. Cell interactions with the materials in vitro will be assessed by seeding cells, measuring metabolic activity, activity of the enzyme alkaline phosphatase and production of markers such as osteocalcin. Final mineralisation will be measured by labeling calcium ions deposited by cells using tetracycline staining. Progression of cells through the differentiation pathway will be measured using real-time RT-PCR analysis of osteocalcin, osterix alkaline phosphatase and collagen I. Work Programme: Electrospinning PgGA: IC (Month 0-6) Characterisation of electrospun fibres: IC (Month 3-12) Manufacture and characterisation of bioceramic BCT (Month 12-18) Functionalisation of fibres: IC (Month 18-21) Engineering of fibre/bioceramic composites: BCT + IC (Month 22-28) In vitro cell biocompatibility assays on fibres and composites: IC (Month 29-36) Scale-up and sterile manufacture of fibre materials: BCT + IC (Month 37-42) Collaborative arrangements: The PhD at Imperial College will be coordinated by Dr Molly Stevens in collaboration with BioCeramic Therapeutics Ltd
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
脊髓新鉴定SNAPR神经元相关环路介导SCS电刺激抑制恶性瘙痒
  • 批准号:
    82371478
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    焦英甫
  • 依托单位:
tau轻子衰变与新物理模型唯象研究
  • 批准号:
    11005033
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2010
  • 负责人:
    李文君
  • 依托单位:
HIV gp41的NHR区新靶点的确证及高效干预
强子对撞机上新物理信号的多轻子末态研究
  • 批准号:
    10675110
  • 项目类别:
    面上项目
  • 资助金额:
    36.0万元
  • 批准年份:
    2006
  • 负责人:
    蒋一
  • 依托单位: